The long and the short of bone therapy. [N Engl J Med. 2006]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: N Engl J Med. 2006 Feb 23;354(8):860-3. Links

The long and the short of bone therapy.

PMID: 16495400 [PubMed - indexed for MEDLINE]

Denosumab in postmenopausal women with low bone mineral density.
N Engl J Med. 2006 Feb 23; 354(8):821-31.

[N Engl J Med. 2006]
ReviewEffect of RANKL-specific denosumab on osteoclast number and function: a potential friend or foe?
Curr Opin Investig Drugs. 2007 Oct; 8(10):830-5.

[Curr Opin Investig Drugs. 2007]
Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG).
Ann Endocrinol (Paris). 2006 Apr; 67(2):139-41.

[Ann Endocrinol (Paris). 2006]
RANKL inhibitors: a bright future?
Joint Bone Spine. 2006 Mar; 73(2):129-31. Epub 2005 Dec 1.

[Joint Bone Spine. 2006]
Review[A new treatment for osteoporosis using fully human monoclonal antibody to RANKL, AMG 162]
Clin Calcium. 2005 Jan; 15(1):43-8.

[Clin Calcium. 2005]
» See reviews... | » See all...

ReviewClinical development of anti-RANKL therapy.
Schwarz EM, Ritchlin CT. Arthritis Res Ther. 2007; 9 Suppl 1:S7.

[Arthritis Res Ther. 2007]

Your browsing activity is empty.

Activity recording is turned off.

Display Show